SERA / Sera Prognostics, Inc. (SERA) CEO Greg Critchfield on Q2 2022 Results - Earnings Call Transcript

Sera Prognostics, Inc. (SERA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combin more_horizontal

The heavy selling pressure might have exhausted for Sera Prognostics, Inc. (SERA) as it is technically in oversold territory now. In addition to this more_horizontal

Sera Prognostics, Inc. (NASDAQ:SERA ) Q2 2023 Earnings Conference Call August 9, 2023 5:00 PM ET Company Participants Peter DeNardo – Investor Relat more_horizontal

Sera Prognostics is a promising company with a mission to improve pregnancy outcomes through its blood test product, PreTRM, which identifies biomarke more_horizontal

Sera Prognostics, Inc. (SERA) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares more_horizontal

Sera Prognostics, Inc. (NASDAQ:SERA ) Q4 2022 Earnings Conference Call March 22, 2023 5:00 PM ET Company Participants Peter DeNardo - CapComm Partners more_horizontal

Sera Prognostics, Inc. (SERA) delivered earnings and revenue surprises of 26.19% and 50%, respectively, for the quarter ended December 2022. Do the nu more_horizontal

The stock price of Sera Prognostics Inc (NASDAQ: SERA) surged by 127.69% this past week. This is why. more_horizontal